Health Care & Life Sciences » Pharmaceuticals | Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc. | Ownership

Companies that own Ritter Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Alyeska Investment Group LP
293,059
5.3%
-149,170
0.01%
06/30/2018
Baker Bros. Advisors LP
279,999
5.05%
0
0%
06/30/2018
DRW Securities LLC
43,310
0.78%
14,000
0.01%
06/30/2018
Renaissance Technologies LLC
34,819
0.63%
24,769
0%
06/30/2018
The Vanguard Group, Inc.
14,030
0.25%
14,030
0%
06/30/2018
Armistice Capital LLC
14,000
0.25%
-176,000
0%
06/30/2018
SignatureFD LLC
13,000
0.24%
13,000
0%
06/30/2018
BlackRock Fund Advisors
9,333
0.17%
712
0%
06/30/2018
City National Rochdale LLC
1,200
0.02%
0
0%
06/30/2018
Wells Fargo Clearing Services LLC
1,100
0.02%
0
0%
06/30/2018

About Ritter Pharmaceuticals

View Profile
Address
1880 Century Park East
Los Angeles California 90067
United States
Employees -
Website http://www.ritterpharmaceuticals.com
Updated 07/08/2019
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.